BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8844560)

  • 21. A control/experimental trial of an operant treatment for early stuttering.
    Onslow M; Andrews C; Lincoln M
    J Speech Hear Res; 1994 Dec; 37(6):1244-59. PubMed ID: 7877284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II trial of the Westmead Program: syllable-timed speech treatment for pre-school children who stutter.
    Trajkovski N; Andrews C; Onslow M; O'Brian S; Packman A; Menzies R
    Int J Speech Lang Pathol; 2011 Dec; 13(6):500-9. PubMed ID: 22070727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Speech restructuring group treatment for 6-to-9-year-old children who stutter: A therapeutic trial.
    Euler HA; Merkel A; Hente K; Neef N; Wolff von Gudenberg A; Neumann K
    J Commun Disord; 2021; 89():106073. PubMed ID: 33444874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telehealth adaptation of the Lidcombe Program of Early Stuttering Intervention: five case studies.
    Wilson L; Onslow M; Lincoln M
    Am J Speech Lang Pathol; 2004 Feb; 13(1):81-93. PubMed ID: 15101816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procedures used for assessment of stuttering frequency and stuttering duration.
    Jani L; Huckvale M; Howell P
    Clin Linguist Phon; 2013 Dec; 27(12):853-61. PubMed ID: 23848369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Camperdown Program for adults who stutter: a student training clinic Phase I trial.
    Cocomazzo N; Block S; Carey B; O'Brian S; Onslow M; Packman A; Iverach L
    Int J Lang Commun Disord; 2012; 47(4):365-72. PubMed ID: 22788223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical training model for students: intensive treatment of stuttering using prolonged speech.
    Georgieva D; Stoilova R
    Codas; 2018 Oct; 30(5):e20170259. PubMed ID: 30365650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trial: the use of SpeechEasy® in stuttering treatment.
    Ritto AP; Juste FS; Stuart A; Kalinowski J; de Andrade CR
    Int J Lang Commun Disord; 2016 Nov; 51(6):769-774. PubMed ID: 27271500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinician percent syllables stuttered, clinician severity ratings and speaker severity ratings: are they interchangeable?
    Karimi H; Jones M; O'Brian S; Onslow M
    Int J Lang Commun Disord; 2014; 49(3):364-8. PubMed ID: 24304909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of intensive, group therapy for teenagers who stutter.
    Fry J; Millard S; Botterill W
    Int J Lang Commun Disord; 2014; 49(1):113-26. PubMed ID: 24102885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speech naturalness and prolonged-speech treatments for stuttering: further variables and data.
    Onslow M; Hayes B; Hutchins L; Newman D
    J Speech Hear Res; 1992 Apr; 35(2):274-82. PubMed ID: 1573867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal variability in sung productions of adolescents who stutter.
    Falk S; Maslow E; Thum G; Hoole P
    J Commun Disord; 2016; 62():101-14. PubMed ID: 27323225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate effects of AAF devices on the characteristics of stuttering: a clinical analysis.
    Unger JP; Glück CW; Cholewa J
    J Fluency Disord; 2012 Jun; 37(2):122-34. PubMed ID: 22531287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of stuttering frequency during and after speech initiation in unaltered feedback, altered auditory feedback and choral speech conditions.
    Saltuklaroglu T; Kalinowski J; Robbins M; Crawcour S; Bowers A
    Int J Lang Commun Disord; 2009; 44(6):1000-17. PubMed ID: 19294550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-modelling as a relapse intervention following speech-restructuring treatment for stuttering.
    Cream A; O'Brian S; Onslow M; Packman A; Menzies R
    Int J Lang Commun Disord; 2009; 44(5):587-99. PubMed ID: 19925353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The validity of a simple outcome measure to assess stuttering therapy.
    Huinck W; Rietveld T
    Folia Phoniatr Logop; 2007; 59(2):91-9. PubMed ID: 17337899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Percentage of Syllables Stuttered With Parent-Reported Severity Ratings as a Primary Outcome Measure in Clinical Trials of Early Stuttering Treatment.
    Onslow M; Jones M; O'Brian S; Packman A; Menzies R; Lowe R; Arnott S; Bridgman K; de Sonneville C; Franken MC
    J Speech Lang Hear Res; 2018 Apr; 61(4):811-819. PubMed ID: 29554191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The perception of speech naturalness of post-therapeutic and altered auditory feedback speech of adults with mild and severe stuttering.
    Stuart A; Kalinowski J
    Folia Phoniatr Logop; 2004; 56(6):347-57. PubMed ID: 15557773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining clinically significant changes in the treatment of child stutterers.
    Gagnon M; Ladouceur R
    Percept Mot Skills; 1991 Oct; 73(2):375-8. PubMed ID: 1766758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A three-arm randomized controlled trial of Lidcombe Program and Westmead Program early stuttering interventions.
    Trajkovski N; O'Brian S; Onslow M; Packman A; Lowe R; Menzies R; Jones M; Reilly S
    J Fluency Disord; 2019 Sep; 61():105708. PubMed ID: 31121476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.